Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes
Tomoya Isobe, Iwo Kuciński, Melania Barile, Xiaonan Wang, Rebecca Hannah, Hugo Bastos, Shirom Chabra, M. S. Vijayabaskar, Katherine Sturgess, Matthew Williams, George Giotopoulos, Ludovica Marando, Juan Li, Justyna Rak, Malgorzata Gozdecka, Daniel Prins, Mairi Shepherd, Sam Watcham, Anthony R. Green, David G. Kent, George S. Vassiliou, Brian J.P. Huntly, Nicola K. Wilson, Berthold Göttgens
Abstract
Acute myeloid leukemia (AML) and myeloid neoplasms develop through acquisition of somatic mutations that confer mutation-specific fitness advantages to hematopoietic stem and progenitor cells. However, our understanding of mutational effects remains limited to the resolution attainable within immunophenotypically and clinically accessible bulk cell populations. To decipher heterogeneous cellular fitness to preleukemic mutational perturbations, we performed single-cell RNA sequencing of eight different mouse models with driver mutations of myeloid malignancies, generating 269,048 single-cell profiles. Our analysis infers mutation-driven perturbations in cell abundance, cellular lineage fate, cellular metabolism, and gene expression at the continuous resolution, pinpointing cell populations with transcriptional alterations associated with differentiation bias. We further develop an 11-gene scoring system (Stem11) on the basis of preleukemic transcriptional signatures that predicts AML patient outcomes. Our results demonstrate that a single-cell-resolution deep characterization of preleukemic biology has the potential to enhance our understanding of AML heterogeneity and inform more effective risk stratification strategies.